Skip to main content
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Subscribe
Home
Issues
Issue Archive
Topics
Conference Correspondent
Multimedia
Videos
Interview with the Innovators
Editorial Board
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Process
Advertising Policy
Acute Lymphoblastic Leukemia
Online Only
Original Research
,
Acute Lymphoblastic Leukemia
,
Anticoagulants
,
Thromboembolism
Evaluation of Clotting and Bleeding Risk Associated With the Use of Asparaginase Drugs in Patients With Acute Lymphoblastic Leukemia
Alyssa Cendagorta, PharmD, BCOP; Frank Lattuca, PharmD, BCOP; Jeremiah E. Moore, PharmD, BCOP; Kristen O’Dwyer, MD; Andrea Baran, MS; Nicole M. Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP; Carissa Treptow, PharmD, BCOP
Read More
Results 1 - 1 of 1
